
You can purchase shares of HIKMA PHARMACEUTICALS PLC by Hikma Pharmaceuticals plc. (OTCPK:HKMPF) through any online brokerage.
There are no as such competitors for HIKMA PHARMACEUTICALS PLC by Hikma Pharmaceuticals plc..
There is no analysis for HIKMA PHARMACEUTICALS PLC by Hikma Pharmaceuticals plc. to provide a consensus price target.
The stock price for HIKMA PHARMACEUTICALS PLC by Hikma Pharmaceuticals plc. (OTCPK: HKMPF) is $23.585 last updated November 4, 2026 at 9:30 AM EST.
There are no upcoming dividends for HIKMA PHARMACEUTICALS PLC by Hikma Pharmaceuticals plc..
HIKMA PHARMACEUTICALS PLC by Hikma Pharmaceuticals plc. does not have any upcoming earnings scheduled.
There is no upcoming split for HIKMA PHARMACEUTICALS PLC by Hikma Pharmaceuticals plc..
HIKMA PHARMACEUTICALS PLC by Hikma Pharmaceuticals plc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.
Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, Rx, and branded. The majority of the...